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Cellular metabolism is central to many specific functions of immune cells. Accordingly, the interplay between metabolism and specific functions of immune cells has emerged as key focus in immunological research ([@bib9]). Macrophages represent the first line of immune defense against pathogens. Upon activation, they undergo massive metabolic reprogramming to allow execution of specialized programs such as phagocytosis ([@bib2], [@bib43], [@bib55]). An appropriate metabolic response requires the cell to rapidly interact with its environment for nutrient uptake and ion transport ([@bib32], [@bib52]). Movement of metabolites and molecules across cellular membranes is mainly achieved by transporter proteins, such as solute carriers (SLCs), which represent the largest group of facilitative and concentrative transporters in the human genome ([@bib10]).

We hypothesized that SLCs could be essential for macrophages to undergo the metabolic changes associated with phagocytosis, and aimed for an appropriate model system suitable for CRISPR/Cas9-based genetic screens ([Figure 1](#fig1){ref-type="fig"}A).Figure 1SLC-Focused CRISPR/Cas9 Genetic Loss-of-Function Screens Identify SLC4A7 to Be Important for Phagosome Acidification(A) Schematic representation of the major steps of the SLC-focused CRISPR/Cas9 screen to identify SLCs involved in phagocytosis.(B) Representative flow cytometry scatterplot of phagocytosis assays. PMA-differentiated U937 cells were incubated with dual-colored opsonized beads. Each dot represents one cell: intensity of the pH-insensitive dye (YG) is displayed on the x axis, intensity of pH-sensitive dye (pHrodo-Red), whose signal intensity increases with decrease in pH, is shown on the y axis. Double-negative cells were classified as phagocytosis-negative (PhagoNeg), double-positive cells (YG and high pHrodo-Red signal) were classified as cells having undergone phagocytosis and phagosome acidification (PhagoLate), and single positive cells (YG and low pHrodo-Red signal) were classified as cells at early stages of phagocytosis (PhagoEarly). The marginal intensity distributions are shown on the sides of the plot.(C) Volcano plot showing the statistical significance of genes depleted in the PhagoLate population on the y axis as --log~10~(p~adj~) against average log~2~ fold-change (mean LFC) on the x axis calculated for all sgRNAs per gene. The size of the dots represents the number of significant changes in sgRNAs counts. See [Figure S1](#mmc1){ref-type="supplementary-material"}B for differential abundance of individual sgRNAs.(D) Immunoblot analysis of primary human monocytes (Mo) derived from peripheral blood and M-CSF-differentiated monocyte-derived human macrophages, which were unpolarized (M0), or polarized toward M1 phenotype with interferon-γ and lipopolysaccharide, or to M2 phenotype with interleukin-4. Respective lysates were probed with an anti-SLC4A7 antibody detecting all isoforms (C-terminal epitope) and an anti-SLC4A7 antibody detecting an N-terminal epitope present only in isoforms starting with the amino acids "MEAD." Actin was used as loading control. MW, molecular weight. See [Figure S1](#mmc1){ref-type="supplementary-material"}C for isoforms.(E) Representative immunoblot analysis of SLC4A7 expression in undifferentiated and PMA-differentiated THP-1 and U937 cells. Actin was used as loading control. MW, molecular weight.(F) Representative kinetics of phagosome acidification in four independent SLC4A7 knockout (sg1-sg4) and control (sgRen) U937 cells. After PMA differentiation, U937 cells were incubated with dual-colored beads and analyzed at the indicated time points using flow cytometry. The fraction of PhagoLate cells is displayed against the incubation time with beads. See [Figure S1](#mmc1){ref-type="supplementary-material"}D for confirmation of SLC4A7 knockdown.(G) Phagocytosis assays with PMA-differentiated SLC4A7 knockout (sg1) or control (sgRen) THP-1 cells, which were incubated with dual-colored beads as described in [(B](#fig1){ref-type="fig"}). Bar graphs show the fraction of PhagoLate, PhagoEarly, and PhagoNeg cells as assessed by pHrodo and YG fluorescence in flow cytometry. Data are mean ± 95% confidence interval from four replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.001; by Welsh\'s t test.

Phagocytosis and phagosome maturation eventually lead to progressive acidification of phagolysosomes ([@bib29]). Phagosome acidification, detected by pH-dependent fluorophores is a valid surrogate endpoint to measure phagocytosis ([@bib15], [@bib20], [@bib42], [@bib58], [@bib61]). We chose phorbol myristate acetate (PMA)-differentiated human myeloid U937 cells as a macrophage model system to detect and quantify phagosome acidification ([@bib33]). We subjected differentiated U937 cells to phagocytosis assays with opsonized latex beads, which were coupled to a pH-sensitive (pHrodo) and a pH-insensitive dye (YG, yellow green) ([Figure 1](#fig1){ref-type="fig"}B) ([@bib15]). The dual-colored beads allowed discrimination between cells that underwent phagocytosis and phagosome acidification (PhagoLate, YG and pHrodo-positive), cells that have bound and/or phagocytosed, but not acidified the cargo (PhagoEarly, only YG-positive), and cells that have neither bound nor incorporated any beads (PhagoNeg) ([Figure 1](#fig1){ref-type="fig"}B).

To validate our experimental strategy, we tested a range of pharmacological and genetic perturbations targeting different stages of the phagocytic process ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Disruption of phagocytic uptake using the actin polymerization inhibitor cytochalasin D led to ablation of the PhagoLate fraction with simultaneous increase of the PhagoNeg, but not the PhagoEarly fraction. By contrast, inhibition of phagosome acidification using the vacuolar-ATPase inhibitor bafilomycin A1 resulted in a strong decrease of the PhagoLate fraction, accompanied by an elevation of the PhagoEarly and, to lesser extent, of the PhagoNeg fraction. CRISPR-mediated knockout of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2 or CYBB), a major producer of reactive oxygen species during phagocytosis, and of Lamp1 or Lamp2, important lysosomal structural proteins, resulted in a slight decrease of the PhagoLate and minor increases in the PhagoEarly and PhagoNeg fractions, corresponding to a slight decrease in phagosome acidification ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Finally, knockout of RAB7A, a small guanosine triphosphatase required for phagosome maturation and phagosome-to-lysosome fusion, strongly reduced the PhagoLate fractions, while strongly increasing the PhagoEarly, but not the PhagoNeg fractions, corresponding to a strong inhibition of phagosome maturation ([@bib56], [@bib63]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A).

Having validated the experimental strategy, we set out to systematically identify SLCs involved in the regulation of phagocytosis. We established a CRISPR/Cas9-based loss-of-function screen using an SLC-wide knockout library, designed in our laboratory, and a fluorescence-activated cell sorting (FACS)-based readout. The pooled library targets 391 human SLC genes with six single guide RNAs (sgRNAs) per gene and additionally comprises sgRNAs targeting essential genes and non-targeting sgRNAs as controls. We infected U937 cells with lentiviral particles carrying the SLC knockout library and differentiated them with PMA to establish a macrophage-like phenotype ([Figure 1](#fig1){ref-type="fig"}A). To identify SLCs essential for phagocytosis, we isolated two populations via FACS: the phagocytosis- and acidification-positive fraction (PhagoLate) and the phagocytosis-negative population (PhagoNeg) ([Figure 1](#fig1){ref-type="fig"}B). After amplification and sequencing of the sgRNAs from each population, the reads were mapped and quantified using a two-step differential abundance analysis. After identifying differentially enriched sgRNAs using DESeq2 ([Figure S1](#mmc1){ref-type="supplementary-material"}B; [Data S1](#mmc4){ref-type="supplementary-material"}) ([@bib38]), we aggregated sgRNAs to genes using the gene set enrichment algorithm ([Figure 1](#fig1){ref-type="fig"}C) ([@bib54], [@bib57]). Strikingly, among all SLCs, SLC4A7 was the only gene significantly depleted from the PhagoLate fraction ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B).

SLC4A7, also known as NBCn1 and NBC3, is an electroneutral sodium bicarbonate co-transporter involved in maintenance of cytosolic pH by extruding acid equivalents ([@bib30], [@bib50]). SLC4A7 has a high number of different isoforms, which show tissue-specific expression and differ in surface abundance and transport activity. They arise from two alternative promotors, three optional structural elements (cassettes I-III), and respective alternative splicing ([Figure S1](#mmc1){ref-type="supplementary-material"}C) ([@bib34], [@bib44], [@bib45]). SLC4A7 is expressed in several cell types and tissues including brain, heart, and kidney ([@bib18], [@bib35], [@bib45], [@bib50]). Although data on SLC4A7 expression in the immune system are scarce, there is evidence for a specific role in macrophages. SLC4A7 was shown to be strongly upregulated upon macrophage colony-stimulating factor (M-CSF)- and receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation ([@bib48]). Moreover, a transcriptional study identified SLC4A7 among the genes differentially expressed during the monocyte-to-macrophage differentiation and polarization ([@bib39]). To further investigate the potential specific role of SLC4A7 in macrophages, we treated primary human monocytes with M-CSF and observed a strong upregulation of SLC4A7 upon macrophage differentiation, suggesting a particular function in macrophage biology ([Figure 1](#fig1){ref-type="fig"}D). Polarization of macrophages to the M1 phenotype or the M2 phenotype did not further modulate SLC4A7 protein abundance ([Figure 1](#fig1){ref-type="fig"}D). Consistently, the expression levels of SLC4A7 in human U937 and THP-1 cells strongly increased upon PMA-induced differentiation toward macrophages ([Figure 1](#fig1){ref-type="fig"}E).

To validate the findings of the CRISPR screen, we generated SLC4A7-deficient U937 cells using four different sgRNAs targeting different exons common to all SLC4A7 isoforms ([Figures S1](#mmc1){ref-type="supplementary-material"}C and [S1](#mmc1){ref-type="supplementary-material"}D). After confirming SLC4A7 knockout efficiency by immunoblot ([Figure S1](#mmc1){ref-type="supplementary-material"}D), we performed phagocytosis assays with the respective U937 cells at different time points. Importantly, at each time point, all four sgRNAs resulted in strongly decreased numbers of PhagoLate cells as compared with control cells infected with a non-targeting sgRNA (sgRen, directed toward *Renilla* luciferase) ([Figure 1](#fig1){ref-type="fig"}F).

If SLC4A7 plays a fundamental role in phagocytosis, it should do so also in other human macrophage model cell lines. We CRISPR/Cas9-inactivated SLC4A7 in human THP-1 myeloid cells and differentiated them with PMA. Phagocytosis assays showed a significant reduction in the PhagoLate fraction upon SLC4A7 knockout, which was accompanied by an increase in the PhagoEarly and, to a minor extent, of the PhagoNeg fraction ([Figure 1](#fig1){ref-type="fig"}G). This pattern was comparable with the phenotype of hampered phagosome acidification ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Therefore, the reduced number of PhagoLate cells was assumed to be the main effect, with the changes in the other fractions being secondary phenomena.

Together, the data demonstrate the general importance of SLC4A7 for phagosome acidification. To test the relevance of these findings for host-pathogen interactions, we subjected SLC4A7 knockout and control U937 cells to phagocytosis assays with pHrodo-labeled heat-inactivated *Staphylococcus aureus*. In analogy to labeled beads, we witnessed a strong decrease in the capacity of SLC4A7 knockout cells for acidification of phagocytosed bacteria ([Figure S1](#mmc1){ref-type="supplementary-material"}E), suggesting that SLC4A7 is important for phagosome acidification of pathogens.

To test the specificity of the phenotype, we undertook reconstitution experiments. Among the different isoforms of SLC4A7, we chose two representative forms: isoform 1 (NBCn1-A), the canonical form, which is mainly expressed in cardiac and skeletal muscle, and isoform 6 (NBCn1-G), the most common form, which is expressed in various tissues and differs from isoform 1 in both N terminus and two splicing cassettes ([Figure S1](#mmc1){ref-type="supplementary-material"}C) ([@bib16], [@bib34]). U937 sgRen and sgSLC4A7 cells were successfully reconstituted with lentiviral overexpression constructs coding for isoform 1 or 6 of SLC4A7, as confirmed by immunoblotting ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Overexpression of both isoforms increased the PhagoLate cell fraction beyond the mere rescue of deficient phagosome acidification ([Figure 2](#fig2){ref-type="fig"}A). Markedly, in U937, isoform 6 appeared to be more potent in increasing phagosome acidification than isoform 1, which could result from its reported higher bicarbonate transport and pH-buffering capacity ([@bib34]). Interestingly, an antibody directed against the N-terminal sequence containing the amino acids "MEAD," present in isoform 6, but not 1 ([Figure S1](#mmc1){ref-type="supplementary-material"}C), confirmed that MEAD-forms of SLC4A7 were induced in macrophages, and hence are of physiological relevance ([Figure 1](#fig1){ref-type="fig"}D). In THP-1 cells, overexpression of both SLC4A7 isoforms also increased the degree of phagosome acidification beyond the mere rescue of the sgSLC4A7 phenotype ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}G). In this cellular context, however, there was no difference between isoform 1 and 6, which may result from the higher baseline phagocytic rate and saturation of the system ([Figure 2](#fig2){ref-type="fig"}B).Figure 2Functional Consequences of SLC4A7 Knockout and Overexpression(A) Phagocytosis assays with control (sgRen) and SLC4A7 knockout (sg1, sg4) U937 cells, which were lentivirally infected to exogenously express HA-tagged SLC4A7 isoform 1, isoform 6, or empty vector control (Ctrl), respectively. Cells were incubated with dual-colored beads as described in [Figure 1](#fig1){ref-type="fig"}B. Bar graphs show the fraction of PhagoLate, PhagoEarly, and PhagoNeg cells as assessed by flow cytometry. Data are mean ± 95% confidence interval from three replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001; by Welsh\'s t test. See [Figure S1](#mmc1){ref-type="supplementary-material"}F for immunoblot confirmation of SLC4A7 knockout and exogenous expression.(B) Phagocytosis assays with control (sgRen) and SLC4A7 knockout (sg1) THP-1 cells, which were lentivirally infected to exogenously express HA-tagged SLC4A7 isoform 1, isoform 6, or empty vector control (Ctrl), respectively. Cells were incubated with dual-colored beads as in [Figures 1](#fig1){ref-type="fig"}B and [2](#fig2){ref-type="fig"}A. Bar graphs show the fraction of PhagoLate, PhagoEarly, and PhagoNeg cells as assessed by flow cytometry. Data are mean ± SD from two replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01; by Welsh\'s t test. See [Figure S1](#mmc1){ref-type="supplementary-material"}G for immunoblot confirmation of SLC4A7 knockdown and exogenous expression.(C) Intracellular killing assay with viable Gram-negative (*E. coli*) and Gram-positive (*Streptococcus pyogenes* ΔSLO, *Staphylococcus carnosus* Schleifer and Fischer, and *Staphylococcus aureus* Newman and USA300) bacteria in control (sgRen), SLC4A7 knockout (sg1), and SLC4A7 knockout reconstituted with SLC4A7 isoform 6 (sg1-SLC4A7(i6)) THP-1 cells. Bar graphs depict the percentage of surviving intracellular bacteria in relation to time point zero. Data are median and interquartile range from three replicates. ns, not significant, ^∗∗∗^p \< 0.001; by Wilcoxon-Mann-Whitney test.(D) Representative confocal immunofluorescence images of endogenous SLC4A7 in control (sgRen) or SLC4A7 knockout (sg1) THP-1 cells. PMA-differentiated cells were fixed and stained with anti-SLC4A7 antibody (green). DNA was counterstained with DAPI (blue). The overlay of both signals is depicted. Scale bars, 5 μm.(E) Representative confocal live-cell immunofluorescence images of THP-1 cells expressing GFP-tagged SLC4A7 isoform 6. After PMA-induced differentiation, cells were incubated with pHrodo-labeled heat-killed *S. aureus* (HKSA, upper panel) or dual-colored beads (pHrodo and bright blue; lower panel). Single channel images and respective overlays are shown. Scale bars, 10 μm. For time-lapse acquisitions, see [Video S1](#mmc3){ref-type="supplementary-material"}.(F) Simultaneous measurement of cytoplasmic and phagosomal pH during phagocytosis using live-cell microscopy. PMA-differentiated control (sgRen) and SLC4A7 knockout (sg1) THP-1 cells were loaded with BCECF-AM, incubated with dual-colored beads (pHrodo and bright blue), and imaged at the indicated time points. Incubation and imaging were done in Hank's balanced salt solution with 10% FCS at 37°C in 5% CO~2~. At each time point, z stacks of five different fields were acquired per replicate. Bar charts represent pHrodo intensities of phagocytosed beads or cytoplasmic pH as calculated based on the BCECF calibration curve. Data are mean and 95% confidence interval from three replicates. ^∗∗∗^p \< 0.001; by Welch\'s t test. For *in situ* calibration of the BCECF 490/440 ratio, see [Figure S2](#mmc1){ref-type="supplementary-material"}A; for example images, see [Figure S2](#mmc1){ref-type="supplementary-material"}B. For simultaneous cytoplasmic and phagosomal pH measurements in THP-1 cells phagocyting heat-killed *S. aureus*, see [Figure S2](#mmc1){ref-type="supplementary-material"}C (left panel), and for U937 cells phagocytosing beads, see [Figure S2](#mmc1){ref-type="supplementary-material"}C (right panel).(G) Schematic representation of the SLC4A7 model with the transmembrane domains (TMDs) of the core domain in yellow and the TMDs of the gate domain in blue. Helix 3 and helix 10, which align to form a continuous helix near the putative substrate binding site, are shown in orange and green, respectively. The residues mutated in the functional studies are shown in red with the isoform1/isoform6 numbering scheme.(H) Phagocytosis assays with two independent U937 clones with SLC4A7 knockout (sg1, sg4) or control (sgRen), which were infected with lentiviral expression constructs coding for Strep-HA-tagged SLC4A7 isoform 6 (SLC4A7(i6)), an isoform 6 mutant lacking amino acids 1,008--1,131 (delC), two different predicted transport mutants (T549I and D811A), or empty vector control (Ctrl). PMA-differentiated cells were incubated with dual-colored beads as in [Figure 1](#fig1){ref-type="fig"}B and analyzed by flow cytometry. Bar graphs show the fraction of PhagoLate cells as assessed by pHrodo fluorescence intensity. Data are mean and 95% confidence interval from two replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001; by Welsh\'s t test. For subcellular localization of the different proteins, see immunofluorescence analysis in [Figure S2](#mmc1){ref-type="supplementary-material"}E.

The microbicidal activity of phagosomes results from direct bacterial killing in an acidic environment and activation of pH-sensitive antimicrobial enzymes ([@bib21]). To test if impaired phagosome acidification upon SLC4A7 loss decreased the intracellular bacterial killing capacity, we performed intracellular bacterial killing assays and infected PMA-differentiated THP-1 cells with Gram-negative (*Escherichia coli* K12) and Gram-positive (*Streptococcus pyogenes* ΔSLO strain and *Staphylococcus carnosus*) bacteria. Importantly, THP-1 cells deficient for SLC4A7 showed a significantly reduced intracellular killing capacity toward *E. coli*, *S. pyogenes*, and *S. carnosus*, compared with control cells ([Figure 2](#fig2){ref-type="fig"}C, left panel). Upon reconstitution of knockout cells with SLC4A7 isoform 6, the phenotype was rescued and normal intracellular bactericidal capacity restored ([Figure 2](#fig2){ref-type="fig"}C, left panel). Next, we performed intracellular killing assays with the *S. aureus* strains Newman and USA300, which both stem from clinical isolates. While Newman is pH sensitive, USA300 depends on phagosome acidification for intracellular survival and proliferation within macrophages ([@bib62]). In line with previous results, SLC4A7-deficient THP-1 cells displayed a reduced killing capacity toward the *S. aureus* Newman strain. In contrast, killing of the *S. aureus* USA300 strain was increased in the knockout cells compared with control ([Figure 2](#fig2){ref-type="fig"}C, right panel), suggesting impaired intracellular survival due to reduced acidification. Taken together, these data provide strong evidence for the importance of SLC4A7 in efficient phagosome acidification and microbicidal potency of the cells.

Given its role in bicarbonate transport and pH regulation, and the evidence that SLC4A7 isoforms with distinct bicarbonate transport capacity differentially affected phagosome acidification ([Figure 2](#fig2){ref-type="fig"}B), it can be concluded that SLC4A7-mediated bicarbonate transport is essential for proper phagosome acidification. If located at phagosomal membranes, SLC4A7 could theoretically affect phagosomal pH directly. By contrast, if localized exclusively at the plasma membrane, the mechanism would likely be indirect via regulation of cytoplasmic pH. Visualization of endogenous SLC4A7 in PMA-differentiated THP-1 cells using indirect immunofluorescence revealed a predominant localization of SLC4A7 at the plasma membrane ([Figure 2](#fig2){ref-type="fig"}D), which is in line with previous reports ([@bib36], [@bib65]). To investigate the dynamic localization of SLC4A7 during phagocytosis, we expressed GFP-tagged SLC4A7 isoform 6 in THP-1 cells and exposed them to pHrodo-labeled heat-inactivated *S. aureus* or dual-colored (pHrodo and bright blue) beads. Live-cell microscopy including time-lapse imaging confirmed the cell surface localization of SLC4A7 ([Figure 2](#fig2){ref-type="fig"}E; [Video S1](#mmc3){ref-type="supplementary-material"}). Importantly, no association of SLC4A7 with the phagosomal cargo could be observed during the phagocytic process ([Figure 2](#fig2){ref-type="fig"}E; [Video S1](#mmc3){ref-type="supplementary-material"}).

To test the hypothesis that SLC4A7 regulates phagosome acidification indirectly via dynamic cytoplasmic pH regulation, we undertook live-cell microscopy-based experiments. Using the ratiometric cytoplasmic pH indicator, BCECF-AM, and pHrodo-coated bacteria and beads, we simultaneously measured cytosolic and phagosomal pH at different time points during the phagocytic process ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). At 1 hr after onset of phagocytosis of beads, neither average pHrodo intensity nor cytoplasmic pH differed between SLC4A7 knockout and control THP-1 cells ([Figure 2](#fig2){ref-type="fig"}F). At 6 hr, however, with increasing phagosome acidification, differences became apparent: while the phagosomal cargos were less acidified in SLC4A7 knockout cells, the cytoplasm was significantly more acidic ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}C). Reduced phagosome acidification accompanied by more acidic cytoplasmic pH upon SLC4A7 knockout was consistently observed across different cell lines (THP-1 and U937) and phagosomal cargos (beads and heat-killed *S.aureus*) ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}C).

Together with its specific upregulation upon macrophage differentiation, these findings argue against a general housekeeping role of SLC4A7 in cytosolic pH homeostasis. Instead, SLC4A7 seems to be of particular relevance for counteracting cytoplasmic acidification during the phagocytic process.

We next wanted to investigate whether bicarbonate transport was essential for SLC4A7-mediated pH regulation. As the 3D structure of SLC4A7 is unknown, we generated a model of the transmembrane region of SLC4A7 with the I-Tasser Suite ([@bib68]), using the available SLC4A1 structure as a template (PDB: 4YZF; [@bib1]). The C-terminal domain of SLC4A7 shares 42% sequence identity with the corresponding domain of SLC4A1, and the model closely resembles the overall SLC4A1 architecture ([Figure 2](#fig2){ref-type="fig"}G). Mapping of functionally important residues on our model identified Asp930 (Asp811 in isoform 6) and Thr668 (Thr549 in isoform 6) as positions likely to be required for transporter activity ([Figure 2](#fig2){ref-type="fig"}G). Asp930 corresponds to SLC4A1 Glu681, a residue critical for anion exchange, while Thr668 corresponds to Ser465 in SLC4A1, a position tolerating only conservative mutations ([@bib12], [@bib3], [@bib8]). We generated mutant versions of SLC4A7 isoform 6 carrying the Asp811Ala (D811A) or the Thr549Ile (T549I) point mutation ([Figure 2](#fig2){ref-type="fig"}G). In addition, we generated a deletion mutant lacking the cytoplasmic C-terminal domain of SLC4A7, which contains a PDZ domain and is essential for membrane localization and function of SLC4A7 ([@bib36]). We used all three mutants to reconstitute U937 cells lacking endogenous SLC4A7. Importantly, both the D811A and T549I transport mutants showed expression levels and subcellular localization comparable with the wild-type protein, whereas the C-terminal deletion mutant failed to localize to the plasma membrane ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E) ([@bib36]). Notably, neither wild-type nor mutated SLC4A7 co-localized with the lysosomal marker Lamp1 ([Figure S2](#mmc1){ref-type="supplementary-material"}E). In contrast to the wild-type protein, none of the three SLC4A7 mutants was able to rescue the phenotype of SLC4A7 knockout ([Figure 2](#fig2){ref-type="fig"}H). Whereas failure of the deletion mutant to rescue could be explained by its mislocalization ([Figure S2](#mmc1){ref-type="supplementary-material"}E), the inability of both point mutants to rescue phagosome acidification suggested that transporter activity is essential for the biological function of SLC4A7. This supports the assumption that bicarbonate import into the cytosol is essential for cytosolic pH homeostasis and efficient phagosome acidification.

How Do We Envisage the Role of SLC4A7 in the Regulation of Phagocytosis? {#sec1.1}
------------------------------------------------------------------------

The process of phagocytosis is associated with a rapid and transient acidification of the cytoplasm, which is believed to result from both respiratory burst and increased metabolic acid production ([@bib14], [@bib24], [@bib40], [@bib59]). Failure to counterbalance the cytoplasmic acidification results in cytoplasmic hyper-acidification, which, among others, inhibits the NADPH oxidase and reduces phagosome acidification ([@bib14], [@bib40]). So far, it was assumed that Na^+^/H^+^ exchangers, passive proton conductance channels, and voltage-gated proton channels are the main players responsible for counteracting the initial cytoplasmic acidification ([@bib14], [@bib40]). However, many studies were undertaken in nominally bicarbonate-free buffers, suggesting that the impact of bicarbonate transporters might have been overlooked.

The strong induction of SLC4A7 during macrophage differentiation, and the failure to maintain cytoplasmic pH during phagocytosis upon genetic inactivation, suggest SLC4A7 to be of key importance for pH homeostasis in phagocyting macrophages. Cell surface localization of SLC4A7 and the inability of transport mutants to maintain the biological function of SLC4A7 support a model in which SLC4A7-mediated bicarbonate import into the cytoplasm is crucial for net acid extrusion and maintenance of cytoplasmic pH during phagocytosis. Acidification of the cytoplasm, observed upon SLC4A7 loss, results in impaired acidification of phagosomes and reduced bactericidal capacity ([@bib14], [@bib24], [@bib40], [@bib25]).

Phagocytosis, a defining function of macrophages, is a fundamental process throughout macrophage-mediated immunity, starting from the first-line host defense against invading pathogens to removal of apoptotic cell debris associated with tissue remodeling and homeostasis. Given that SLC4A7 affected intracellular bacterial killing or intracellular survival of acid-sensitive and acid-dependent bacteria, respectively, we assume that a wide range of pathogens, including also viruses or parasites, may be affected by SLC4A7 function. This opens the possibility of modulating the activity of this transporter as anti-infective strategy ([@bib26], [@bib27], [@bib62], [@bib67]). Failure to remove dead cells and debris in SLC4A7 deficiency may lead to prolonged inflammatory conditions, which in turn may be associated with different pathologies, including cancer, extending the relevance of SLC4A7 function beyond infectious diseases ([@bib41], [@bib60]).

Irrespectively, the unequivocal role of SLC4A7 in phagosome acidification of macrophages is surprising, as the protein had not been previously associated with any immune function ([@bib6], [@bib11], [@bib37]).

This initial study will clearly have to be followed by animal studies, empowered, for example, by available knockout mice illuminating the role of SLC4A7 in animal physiology ([@bib7], [@bib31]). Nonetheless, the fundamental contribution of SLC4A7 to phagosome acidification is another case where a member of the SLC family is discovered to regulate fundamental biological processes ([@bib46], [@bib51], [@bib66]). The approach described here, employing a CRISPR/Cas9 library focusing on the entire SLC family allowing for analyses with high coverage and great statistical power, is likely to be instrumental in the uncovering of more roles for this still poorly characterized class of drug targets ([@bib10], [@bib32]).

STAR★Methods {#sec2}
============

Key Resources Table {#sec2.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-SLC4A7, rabbit polyclonalAbcamCat\#82335; RRID: [AB_10672662](nif-antibody:AB_10672662){#intref0010}Anti-SLC4A7, serum from rabbit immunized with the SLC4A7 N-terminal peptide MEADGAGEQMRPLLTRGPDEGift from Prof. J. Praetorius (Aarhus University, Denmark)([@bib17])Anti-HA, rabbit monoclonalCell signalingCat\#3724; RRID: [AB_1549585](nif-antibody:AB_1549585){#intref0015}Anti-pan actin, rabbit polyclonalCytoskeletonCat\#AAN01; RRID: [AB_10708070](nif-antibody:AB_10708070){#intref0020}Anti-LAMP1, mouse monoclonalAbcamCat\#25630; RRID: [AB_470708](nif-antibody:AB_470708){#intref0025}Goat anti-mouse IgG, Alexa-Fluor 488 coupledLife TechnologiesCat\#A-11001; RRID: [AB_2534069](nif-antibody:AB_2534069){#intref0030}Donkey anti-rabbit IgG, Cy5 coupledJackson ImmunoResearchCat\#711-175-152; RRID: AB_2340607Goat anti-rabbit IgG, Peroxidase-conjugatedJackson ImmunoResearchCat\#111-035-003; RRID: [AB_2313567](nif-antibody:AB_2313567){#intref0035}Goat anti-mouse IgG, Peroxidase-conjugatedJackson ImmunoResearchCat\#115-035-003; RRID: [AB_10015289](nif-antibody:AB_10015289){#intref0040}**Bacterial and Virus Strains***Escherichia coli* DH5-alphaNew England BiolabsCat\#C2987*Streptococcus pyogenes Δ*SLON/A([@bib23])*Staphylococcus carnosus* Schleifer and FischerDSMZCat\# 20501*Staphylococcus aureus* NewmanGift from Arsanis Biosciences GmbH to PKN/A*Staphylococcus aureus* USA300Gift from Prof. S. Knapp (CeMM, Vienna, Austria)N/A**Chemicals, Peptides, and Recombinant Proteins**Fluoresbrite YG Carboxylate Microspheres 1.75μmPolyscienceCat\#17687-5pHrodo Red, succinimidyl ester (pHrodo Red, SE)Thermo Fisher ScientificCat\#P36600PMA, Phorbol 12-myristate 13-acetateSigma-AldrichCat\#P8139Restriction enzyme BsmBINew England BiolabsCat\#R0580BCECF AMThermo Fisher ScientificCat\# B1170**Experimental Models: Cell Lines**THP-1ATCCTIB-202U937Gift from Prof. P. Valent, (Medical University Vienna, Austria)N/AHEK293TDSMZACC 635**Oligonucleotides**See [Table S1](#mmc2){ref-type="supplementary-material"} for oligonucleotides used to clone sgRNAsThis paper, SigmaN/A**Recombinant DNA**lentiCRISPR v2AddgeneCat\#52961psPAX2AddgeneCat\#12260pMD2.GAddgeneCat\#12259pDONR221Thermo Fisher Scientific12536017Codon optimized SLC4A7 isoform 1 and 6 cDNAGenScriptN/A**Software and Algorithms**R (3.4.0)<https://www.r-project.org>N/ARstudio (1.0.143)<https://www.rstudio.com>N/ABioconductor (3.5)<https://bioconductor.org/>N/ADESeq2 (1.16.1)<https://bioconductor.org/>N/AFgsea (1.2.1)<https://bioconductor.org/>N/Aggplot2 (2.2.1)<https://cran.r-project.org/>N/ADrc<https://CRAN.R-project.org/package=drc>N/A**Other**RPMI Medium 1640 (1x)GibcoCat\#21875-034DMEM Medium (1x)GibcoCat\# 11965-084DPBS (1x)GibcoCat\#14190-094Fetal Bovine SerumGibcoCat\#10270Pen StrepGibcoCat\#15140-122IC Fixation buffereBioscienceCat\#00-8222-49ProLong Gold Antifade MountantThermo FisherCat\#P10144cOmplete Protease Inhibitor TabletsRocheCat\#04693159001Protein Assay Dye Reagent ConcentrateBioradCat\#5000006Nitrocellulose membranesAmershamCat\#10600002Pierce ECL Western Blotting SubstrateThermo ScientificCat\#32106PolyFectQiagenCat\#301105QuikChange II Site Directed Mutagenesis KitAgilentCat\# 200523

Contact for Reagent and Resource Sharing {#sec2.2}
----------------------------------------

Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Giulio Superti-Furga ([gsuperti\@cemm.oeaw.ac.at](mailto:GSuperti@cemm.oeaw.ac.at){#intref0080}).

Experimental Model and Subject Details {#sec2.3}
--------------------------------------

### Cell Culture {#sec2.3.1}

U937 cells were a gift from Prof. Peter Valent of the Medical University of Vienna, THP-1 cells were purchased from ATCC. Cell lines were tested for mycoplasma with regular intervals. STR profiling was performed for all cell lines to confirm identity.

Cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum and penicillin/streptomycin with 5% CO~2~ at 37°C. U937 cells were maintained at a density of 0.1x10^6^ -- 1x10^6^ cells/ml; THP-1 cells were maintained at 0.5x10^6^ -- 2x10^6^ cells/ml.

### Primary Cells and Monocyte to Macrophage Differentiation {#sec2.3.2}

Human monocytes were isolated from healthy donor peripheral blood buffy coats (obtained from the Austrian Red Cross) by adherence to plastic for 3 h in serum-free RPMI medium ([@bib64]). Monocytes were then differentiated to macrophages for 7 days in RPMI supplemented with 100 ng/ml M-CSF, 10% fetal bovine serum and penicillin/streptomycin. Macrophage polarization was achieved by incubating cells for 18 h in medium with IFNγ (20 ng/ml) and LPS (100 ng/ml) for induction of M1 phenotype or IL-4 (20 ng/ml) for induction of M2 phenotype ([@bib39]).

Monocyte to macrophage differentiation of THP-1 and U937 cells was performed with 10 nM PMA (Sigma) at a cellular density of 1x10^6^ cells/ml for 48 h followed by washing and an additional 24 h resting period.

### Culture and Preparation of Bacteria {#sec2.3.3}

*Escherichia coli* (K12) were inoculated from overnight culture into fresh LB media and grown till mid-log phase (OD~600~ = 0.5). Bacteria were washed in PBS and resuspended to the concentration of 1x10^9^ cfu/ml.

*Staphylococcus carnosus* (Schleifer and Fisher), *Staphylococcus aureus* (USA300, Newman) were plated on trypcase soy agar with 5% sheep blood from cryo stock and grown for 16 h at 37°C. Single colonies were inoculated in 30 ml of brain heart infusion media (BHI) and grown till reaching the stationary phase (16 h). Overnight cultures were diluted in 50 ml of BHI and grown till mid-log phase. Bacteria were washed 2 times in PBS and resuspended at a concentration of 1x10^9^ cfu/ml.

*Streptococcus pyogenes* was inoculated in 5 ml of Todd Hewitt Broth with 0.5% yeast (THY) extract and grown at 37°C in atmosphere with 5% CO~2~ for 16 h. Overnight cultures were diluted in 30 ml of THY and grown till reaching mid-log phase. Bacteria were washed 2 times in PBS and resuspended at the concentration of 1x10^9^ cfu/ml.

Method Details {#sec2.4}
--------------

### SLC-Focused CRISPR/Cas9 Screen {#sec2.4.1}

The SLC KO CRISPR/Cas9 library used will be described in detail in Girardi et al. (in preparation). Briefly, a CRISPR/Cas9 library targeting 391 SLC genes with six sgRNAs per gene, together with a set of 120 sgRNAs targeting 20 genes essential in KBM7 and HAP1 cells ([@bib4]) and a set of 120 non-targeting sgRNAs was cloned by Gibson cloning in the lentiCRISPRv2 lentiviral vector. Viral particles were generated by transient transfection of low passage, subconfluent HEK293T cells with the SLC-targeting library and the packaging plasmids psPAX2 and pMD2.G using PolyFect. After 24 h the media was changed to fresh RPMI media supplemented with 10% FCS and antibiotics. The viral supernatant was collected after 48 h, filtered and stored at -80°C until further use. The supernatant dilution necessary to infect U937 cells at a MOI (multiplicity of infection) of 0.2 -- 0.3 was determined by puromycin survival after transduction as described previously ([@bib53]). U937 cells were infected in triplicates with the SLC KO library at high coverage (1000x) and after selection for 7 days with puromycin (2 μg/ml) an initial sample was collected to control for library composition. Cells were differentiated with PMA (10 nM) to macrophage-like phenotype. Phagocytosis assays were performed with dual-color opsonized latex beads as described in the "[Phagocytosis assay](#sec2.4.3){ref-type="sec"}" section. Phagocytosis positive (PhagoLate) and phagocytosis negative (PhagoNeg) populations were sorted using BD FACS Aria II, with at least 3 million cells per replicate and population. Genomic DNA was extracted using the DNAeasy kit (QIAGEN) and the cassettes containing the sgRNA sequence were amplified with one round of PCR following the procedure described in [@bib28]. The amplified samples were sequenced on a HiSeq2000 (Illumina) at the Biomedical Sequencing Facility (BSF at CeMM, <https://biomedical-sequencing.at>), followed by processing with a custom analysis pipeline (see next section).

### Analysis of CRISPR Screens {#sec2.4.2}

Sequences of sgRNAs were extracted from RNA-Seq reads, matched against the original sgRNA library index and counted using an in-house Python script. To compensate for the noise and off-target action of sgRNAs inherent to CRISPR screening approaches, we used a two-step differential abundance analysis. Differential abundance of sgRNAs was estimated with DESeq2 ([@bib38]). Subsequenly, sgRNAs were sorted by adjusted p-values and aggregated to genes using Gene Set Enrichment Algorithm ([@bib54], [@bib57]).

### Phagocytosis Assay {#sec2.4.3}

Phagocytosis assays were performed as previously described ([@bib15]). Fluoresbrite carboxylated 1.75 μM microspheres (YG: 441 nm excitation, 486 nm emission) were opsonized in 20% human male AB serum in PBS for 16 h at 4°C with constant rotation. Subsequently beads were washed twice with PBS and stained with 2 μg/ml pHrodo-Red, SE for 30 min at room temperature with agitation. After washing, beads were resuspended to a final concentration of 1x10^9^ beads/ml.

PMA-differentiated cells (U937 or THP-1) were seeded on 12-well cell culture coated dishes (1x10^6^ cells/well). Stained beads were added to cells at the indicated MOIs. Dishes were centrifuged at 150 g for 10 min with break set to off. After 30 min incubation, cells were washed three times with warm PBS. Cells were further incubated for the indicated times and then detached by scraping with soft rubber policeman and analyzed by flow cytometry.

### Flow Cytometry {#sec2.4.4}

All data acquisition was performed using the LSR Fortessa II cytometer interfaced with FACSDiva (BD). FlowJo X software (Tree Star) was used for data analysis and graphical representation.

### Live-Cell Measurements of Cytosolic and Phagosomal pH {#sec2.4.5}

THP-1 and U937 cells were seeded on imaging dishes (ibidi 35 mm dishes with glass bottom) and differentiated with PMA (10 nM) for 48 h. Differentiated cells were washed twice in HBSS and subsequently loaded with BCECF-AM (5 μM) in HBSS with sodium bicarbonate and 10 mM HEPES for 30 min at 37°C. After washing three times in HBSS, the cells were supplemented with HBSS with 10% FBS. Dual-colored beads (pHrodo and bright blue) or pHrodo-coupled heat-killed S.aureus were added to the cells at an MOI of 10. After spinning at 1000 rpm for 2 min, the cells were further incubated in humidified atmosphere at 37°C and 5% CO~2~. Live cell microscopy was performed on a Zeiss Axio Oberver Z1 widefield microscope (at 37°C and in 5% CO~2~) at 1 and 6 h after loading the phagosomal cargo. pHrodo and bright blue signal was acquired in the respective channels (RFP/DAPI). BCECF emission at 525 nm was acquired after both excitation at 440 nm and 490 nm respectively. 5 independent z-stacks were acquired per dish, and three independent replicate dishes imaged per condition.

An *in situ* calibration curve was constructed by incubating cells in potassium buffers with 10 μM valinomycin and 10 μM nigericin with ranging pH (4.0 -- 10.0).

For image analysis, maximum-projections of z-stacks were generated, background signal was subtracted and signal intensity in respective channels was measured in the respective regions of interest (cytoplasm of cells having undergone phagocytosis; acidified phagosomal particles).

### Immunofluorescence {#sec2.4.6}

For immunofluorescence, THP-1 cells or U937 cells were seeded on glass coverslips and differentiated with PMA for 48 h. For staining of endogenous SLC4A7, PMA-differentiated control (sgRen) and SLC4A7 knockout (sg1) THP-1 cells were washed in PBS. Fixation buffer was added for 10 min at RT (room temperature), cells were washed in PBS again and ice-cold methanol was added for 10 min at 4°C. Subsequently, cells were blocked in IF buffer (2.5% BSA, 0.5% Tween in PBS) for 30 min and next incubated with anti-SLC4A7 (rabbit) primary antibody (at 1:200 dilution) in IF buffer over night. After washing 3 times, Alexa Fluor 488-coupled anti-rabbit (Life Technologies) was added at a dilution of 1:1000. DAPI was used to counterstain DNA and slides were mounted with ProLong Gold Antifade Mountant.

For localization of SLC4A7 isoform 1, isoform 6, and the respective SLC4A7 mutants, U937 cells expressing Strep-HA-tagged forms of SLC4A7 were subjected to the same fixation procedure and incubated with anti-HA (rabbit) and anti-Lamp1 (mouse) primary antibodies (at a 1:1000 and 1:200 dilution in IF buffer respectively), and Alexa Fluor 488-coupled anti-mouse (Life Technologies) and Cy5-coupled anti-rabbit (Jackson ImmunoResearch) secondary antibodies respectively.

Images were taken using a laser-scanning confocal microscope LSM700 (Zeiss).

For live-cell microscopy of GFP-SLC4A7 expressing THP-1 cells, these cells were seeded on chambered coverslips (ibidi) and differentiated with PMA (10 nM) for 48 h. Media was replaced by HBSS with 10 mM of HEPES and 10% of FBS, and dual-colored beads (pHrodo and bright blue) or pHrodo-coupled heat-killed S.aureus were added to the cells at an MOI of 10. After spinning at 1000 rpm for 2 min, the cells were further incubated in humidified atmosphere at 37°C and 5% CO~2~. Live cell microscopy including time-lapse series was performed on a laser-scanning confocal microscope LSM780 (Zeiss) at 37°C and in 5% CO~2~.

### Cell Lysis and Immunoblotting {#sec2.4.7}

Cell samples were lysed in lysis buffer (NaCl 150 mM, Tris-HCl 50 mM, MgCl~2~ 5 mM, EDTA 1 mM, NP-40 0.5 %, Glycerol 5 %) to which cOmplete Protease Inhibitor Tablets were added. After lysis in appropriate volumes and 20 min incubation on ice, cellular lysates were centrifuged at 14000 rpm and 4°C for 15 min to separate from cellular debris, protein concentration was measured according to the Bradford method using Protein Assay Dye Reagent Concentrate, and Laemmli buffer was added. The lysates were separated by SDS-PAGE and blotted onto nitrocellulose membranes. After blocking unspecific binding in 5% milk in TBS-T, membranes were incubated with primary antibodies diluted in 5% milk or 5% BSA (bovine serum albumin) in TBS-T. After addition of peroxidase coupled secondary antibodies, immunoblot membranes were developed using the ECL (enhanced chemoluminescence) method.

### DNA Plasmids and Cloning {#sec2.4.8}

Codon-optimized cDNA for SLC4A7 isoform 1 and isoform 6 was synthesized by GenScript. After sequence verification, both cDNAs were first cloned into the pDONR221 plasmid and then shuttled into a modified pRRL-based lentiviral expression plasmid generated in our lab, which contains an N-terminal Strep-HA tag and a blasticidin resistance cassette. The cDNA of isoform 6 was additionally shuttled into another modified pRRL-based lentiviral expression plasmid generated in our lab, which contains an N-terminal GFP tag and a hygromycin resistance cassette.

The C-terminal deletion mutant of SLC4A7 isoform 6, lacking amino acids 1008-1131, was generated by PCR with respective primers and cloned as described above. For generation of the two SLC4A7 point mutants T549I and D811A, mutagenesis primers were designed using the QuikChange Primer Design tool from Agilent. Mutagenesis was performed using the QuikChange II Site-Directed Mutagenesis Kit (Agilent), following the instructions of the manufacturer. After sequence verification, the cDNAs were shuttled into the pRRL plasmid described above.

sgRNAs were cloned into Bsm BI sites of lentiCRISPR v2.

### Lentivirus-Mediated DNA Transfer {#sec2.4.9}

For lentivirus production, HEK 293T cells were transfected with the sgRNA or expression plasmid, the envelope plasmid pMD2.G and the packaging plasmid psPAX2 using PolyFect. 48 h after transfection, the virus-containing medium was collected and filtered. For infection, THP-1 and U937 cells were plated in 6 well plates, in 2 ml of fresh medium,1 ml of harvested virus and 8 μg/ml protamine sulphate, spin infected at 2000 rpm for 45 min and incubated with the virus-containing supernatant for 24 h. Next day, medium was exchanged. Three days after infection, selection was started by addition of blasticidin (30 μg/ml) or puromycin (2 μg/ml) respectively.

### Gentamicin Protection Assay {#sec2.4.10}

Gentamycin protection assays were performed as previously described ([@bib19], [@bib47]). Briefly, PMA-differentiated THP-1 cells (0.75x10^6^ cells per well on 24-well plates) were inoculated with bacteria at an MOI of 10. Plates were centrifuged at 150 g for 5 min with break set to off. After 30 min, cells were washed with PBS 3 times and supplemented with fresh medium containing 100 μg/ml gentamicin to remove or kill extracellular bacteria. After 30 min, cells were washed and supplemented with medium containing 5 μg/ml gentamycin. At consecutive time points, SLC4A7 knock-out and control THP-1 cells were lysed and plated on agar to allow for outgrowth of surviving intracellular bacteria.

Quantification and Statistical Analysis {#sec2.5}
---------------------------------------

Exploratory data analysis, visualization, and statistical testing were performed with R-project (<http://www.R-project.org>) using Rstudio IDE. Pair-wise differences in central tendencies were tested using Welch\'s t-test or Wilcoxon-Mann-Whitney-Test as indicated in figure legends. Error bars represent 95% confidence intervals, unless indicated otherwise in the figure legends.

Data and Software Availability {#sec2.6}
------------------------------

sgRNA count data are provided in [Data S1](#mmc4){ref-type="supplementary-material"}.
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